✓Strengths
- Moderate debt: debt-to-equity of 0.58.
- Return on equity is healthy at 79.1%.
- Net profit margin is strong at 446.6%.
- Current assets comfortably cover current liabilities (current ratio 1.95).
- Profit has compounded about 230% a year over five years.
!Watch-points
- Thin interest cover: operating profit covers interest only about -0.1 times.
- Return on capital employed is on the lower side at -0.1%.
- Sales growth has been slow over five years (about -24% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.28
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreModerate
4 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 1,607.65
ROCE-0.09%
ROE79.11%
Debt to Equity0.58
Current Ratio1.95
EPS₩ 1,271.89
PAT Margin446.60%
ICR-0.05
Compounded Sales Growth
10 Years
—
5 Years
-24.11%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
230.06%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
79.11%